id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2002-P-0070-0003,FDA,FDA-2002-P-0070,FDA/DDM to Michael Lisjak,Other,LET-Letter,2002-07-08T04:00:00Z,2002,7,,,2008-04-12T01:26:13Z,,0,0,090000648048cb0b
FDA-2002-P-0070-0002,FDA,FDA-2002-P-0070,FDA,Notice,N-Notice,2002-07-05T04:00:00Z,2002,7,,,2008-04-12T01:26:13Z,,0,0,090000648048cb08
FDA-2002-P-0070-0001,FDA,FDA-2002-P-0070,FDA/DDM to Michael Lisjak,Other,ACK-Acknowledgement Letter,2002-01-25T05:00:00Z,2002,1,,,2008-04-12T01:26:13Z,,0,0,090000648048cace